Rice Hall James & Associates’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Rice Hall James & Associates's NEO Position: Q1 2022 in Review
Rice Hall James & Associates sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 83,103 shares — an estimated $2.83M sold.
Rice Hall James & Associates first reported a position in NEO in Q2 2017 and held it in 19 quarters. The position peaked at $3.53M in Q3 2017. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.
- Rice Hall James & Associates reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
- Rice Hall James & Associates sold 83,103 NeoGenomics shares in Q1 2022, an estimated $2.83M.
- Rice Hall James & Associates first reported a position in NeoGenomics in Q2 2017 and held it in 19 quarters.
- Rice Hall James & Associates's NeoGenomics position peaked at $3.53M in Q3 2017.
- 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.
Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.